← Eichor
Condition: Lower Urinary Tract Symptoms Luts Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Lower Urinary Tract Symptoms Luts

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD
Phase N/A · 2 location(s) · University Hospital, Ghent · NCT06311110Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT07016620US Imaging for the Assessment of LUTS
Phase N/A · 1 location(s) · University of Wisconsin, Madison · NCT06323109MISTER Study: Minimally Invasive Steam Therapy - Russian Effectiveness Registry
NA · 1 location(s) · Sechenov University · NCT07723378Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH
NA · 1 location(s) · Ain Shams University · NCT07722884Prospective Data on Bariatric Surgery Effect on IPSS and LUTS
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT06464822A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
NA · 20 location(s) · Rivermark Medical · NCT06849258Safety and Efficacy of MILEP Versus Standard EEP
NA · 1 location(s) · Sechenov University · NCT06839768HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
NA · 1 location(s) · University of Kansas Medical Center · NCT03802851BPH Global Registry
Phase N/A · 26 location(s) · Société Internationale d'Urologie · NCT05543200Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men with BPH
NA · 3 location(s) · Rigshospitalet, Denmark · NCT05686525The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyp
Phase 4 · 8 location(s) · Xintian Pharmaceutical · NCT05551221Reducing Disparities in Urinary Control Symptoms for Minority Women
NA · 2 location(s) · University of Chicago · NCT06798311Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults
NA · 3 location(s) · Bright Uro · NCT07485205Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia.
NA · 2 location(s) · Taipei Medical University WanFang Hospital · NCT07293442SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate
Phase N/A · 19 location(s) · University Hospital, Basel, Switzerland · NCT05495633Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.
Phase 2 · 1 location(s) · Clinical Academic Center (2CA-Braga) · NCT05401032Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterj
Phase N/A · 1 location(s) · Benaroya Research Institute · NCT07377929Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
NA · 5 location(s) · ProArc Medical · NCT05757687European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms
Phase N/A · 1 location(s) · University of Florence · NCT06564415RCT on Running Water Sound During Urodynamic
NA · 2 location(s) · Princess Margaret Hospital, Hong Kong · NCT07451548Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes
Phase N/A · 1 location(s) · Northwestern University · NCT05898932
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.